Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 216 participants.
Also called NCT02901704
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 216 participants
- Sponsor
- Shanghai AngioCare Medical
- Registry
-
NCT02901704
-
- Other papers using this trial's data
- Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02901704. Randomized; single masking; primary purpose treatment. Start 2016-12 (registry gives no type); primary completion 2018-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension
- Acronym
- Iberis-HTN
- Condition
- Primary Hypertension
- Intervention (Device)
- Renal Denervation System (AngioCare)
- Intervention (Procedure)
- Sham procedure
- Lead sponsor
- Shanghai AngioCare Medical
Record details
- Record id
cardio:ct-nct02901704- Content hash
84bc901e6d870ca08b21c316baca3398dc5b6009e493a05a0ec0e44caee6fa95